Anixa Biosciences
ANIX
ANIX
45 hedge funds and large institutions have $11.7M invested in Anixa Biosciences in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.07% less ownership
Funds ownership: 11.85% → 11.77% (-0.07%)
26% less capital invested
Capital invested by funds: $15.8M → $11.7M (-$4.08M)
Holders
45
Holding in Top 10
–
Calls
$164K
Puts
$26K
Top Buyers
| 1 | +$122K | |
| 2 | +$101K | |
| 3 | +$91.9K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$70.3K |
| 5 |
JPMorgan Chase & Co
New York
|
+$69.2K |
Top Sellers
| 1 | -$347K | |
| 2 | -$266K | |
| 3 | -$79K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$72K |
| 5 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$65.4K |